Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bladder Cancer
100%
Myeloid-derived Suppressor Cells
100%
CXCR2
100%
CXCL2
100%
CD33
33%
Cancer Patients
16%
CD11b+
16%
Phosphorylation
16%
HLA-DR
16%
Cancer Tissue
16%
Cell Trafficking
16%
CD45+
16%
Solid Tumors
8%
T Cell Proliferation
8%
Healthy Controls
8%
Mitogen-activated Protein Kinase
8%
Tumor Cells
8%
Tumor Progression
8%
Peripheral Blood
8%
Inducible Nitric Oxide Synthase
8%
Cell Migration
8%
Patient Prognosis
8%
Cell Expansion
8%
Mechanistic Studies
8%
Disease Stage
8%
P-STAT3
8%
Cellular Accumulation
8%
Advanced Disease
8%
Nuclear factor-κB Pathway
8%
Arginase-1 (Arg-1)
8%
Patient-controlled
8%
Putative Drug Targets
8%
Cell Recruitment
8%
MyD88-dependent
8%
Programmed Death-ligand 1 (PD-L1)
8%
Chemotaxis Assay
8%
Tumor-infiltrating
8%
Bladder Cancer Cell Lines
8%
Cancer Microenvironment
8%
Suppressive Molecules
8%
Immunology and Microbiology
Myeloid-Derived Suppressor Cell
100%
CXCL2
100%
CD33
33%
Cell Migration
25%
HLA-DR
16%
Cancer Tissue
16%
Mitogen
8%
T Cell Proliferation
8%
Mediator
8%
STAT3
8%
Tumor Cell
8%
Chemotaxis
8%
Immunoglobulin Enhancer Binding Protein
8%
Bladder Cancer Cell Line
8%
In Vitro
8%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
CXCL2
100%
CD33
33%
Cell Migration
25%
HLA-DR
16%
Cell Proliferation
8%
extracellular signal regulated kinase
8%
Cancer Cell
8%
Mediator
8%
T Cell
8%
STAT3
8%
Tumor Progression
8%
Immunoglobulin Enhancer Binding Protein
8%
Chemotaxis Assay
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Neoplasm
28%
Diseases
14%
Solid Malignant Neoplasm
14%
Tumor Growth
14%
Mitogen Activated Protein Kinase
14%
Immunoglobulin Enhancer Binding Protein
14%
Myeloid Differentiation Factor 88
14%